Maximus, Inc. (NYSE:MMS) Director Raymond B. Ruddy sold 25,000 shares of the stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $60.39, for a total transaction of $1,509,750.00. Following the completion of the sale, the director now owns 252,552 shares in the company, valued at $15,251,615.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Maximus, Inc. (NYSE MMS) opened at 59.30 on Friday. The company has a 50-day moving average of $60.78 and a 200-day moving average of $61.00. The company has a market cap of $3.85 billion, a P/E ratio of 19.01 and a beta of 1.39. Maximus, Inc. has a 52-week low of $43.69 and a 52-week high of $64.97.
Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million for the quarter, compared to the consensus estimate of $614.12 million. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business’s revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.79 earnings per share. On average, equities research analysts expect that Maximus, Inc. will post $3.12 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th will be issued a $0.045 dividend. The ex-dividend date is Friday, August 11th. This represents a $0.18 annualized dividend and a dividend yield of 0.30%. Maximus’s dividend payout ratio is currently 5.73%.
WARNING: “Maximus, Inc. (MMS) Director Sells $1,509,750.00 in Stock” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://stocknewstimes.com/2017/08/20/maximus-inc-mms-director-sells-1509750-00-in-stock.html.
MMS has been the topic of several analyst reports. Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price on the stock. in a report on Tuesday, July 4th. Jefferies Group LLC lowered shares of Maximus from a “buy” rating to a “hold” rating and raised their price objective for the stock from $63.00 to $64.00 in a report on Friday, May 5th. Maxim Group lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $66.00 price objective on the stock. in a report on Thursday, May 4th. They noted that the move was a valuation call. ValuEngine lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Tuesday, May 16th. Finally, KeyCorp restated a “sector weight” rating on shares of Maximus in a report on Thursday, May 25th. One investment analyst has rated the stock with a sell rating and eight have given a hold rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $62.17.
Hedge funds have recently made changes to their positions in the stock. American International Group Inc. increased its stake in shares of Maximus by 4.1% in the first quarter. American International Group Inc. now owns 166,652 shares of the health services provider’s stock valued at $10,366,000 after buying an additional 6,634 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in shares of Maximus by 2.5% in the first quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the health services provider’s stock valued at $1,020,000 after buying an additional 400 shares in the last quarter. Navellier & Associates Inc increased its stake in shares of Maximus by 10.9% in the first quarter. Navellier & Associates Inc now owns 8,737 shares of the health services provider’s stock valued at $543,000 after buying an additional 856 shares in the last quarter. OppenheimerFunds Inc. increased its stake in shares of Maximus by 19.5% in the first quarter. OppenheimerFunds Inc. now owns 11,010 shares of the health services provider’s stock valued at $685,000 after buying an additional 1,793 shares in the last quarter. Finally, Advantus Capital Management Inc increased its stake in shares of Maximus by 3.1% in the first quarter. Advantus Capital Management Inc now owns 8,298 shares of the health services provider’s stock valued at $516,000 after buying an additional 248 shares in the last quarter. Institutional investors own 97.20% of the company’s stock.
About Maximus
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
